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ABSTRACT  Axons  of  dorsal  root  ganglion  neurons  express  on  their  surfaces  one  or  more 
proteins which are mitogenic for Schwann cells (Salzer, J., R. P.  Bunge, and L. Glaser,  1980, J. 
Cell Biol., 84:767-778). Incubation of co-cultures of dorsal root ganglion neurons and Schwann 
cells  with  4-methylumbelliferyl-/3-D-xyloside,  an  inhibitor  of  proteoglycan  biosynthesis,  de- 
creases the  mitogenic  response  of  the  Schwann  cell  by  over  95%.  The  effect  of  the  /3-D- 
xyloside has been localized to the neurons; pretreatment of neurons but not of Schwann cells 
with the inhibitor causes a marked reduction of the mitogenic response. In addition, Schwann 
cells  treated  with  /~-D-xyloside  are  still  mitogenically  responsive  to  soluble  Schwann  cell 
mitogens  (cholera  toxin  and  glial  growth  factor).  Neurons  treated  with  heparitinase  and 
membrane vesicles prepared from heparitinase-treated neurons show diminished mitogenicity 
for  Schwann cells,  while  other  proteoglycan  lyases  have  no effect.  We  conclude that a cell 
surface heparan sulfate proteoglycan is a component of the Schwann cell mitogen present on 
the surface of dorsal root ganglion neurons. 
During  embryonic  development  of  the  peripheral  nerve 
trunks,  Schwann cells proliferate along the axons which they 
will later ensheath and, in the case of larger axons, myelinate. 
This  early  proliferative  response  can  be  mimicked  in  vitro 
using cultures containing pure populations of embryonic rat 
dorsal  root  ganglion  neurons  and  Schwann  cells  (Wood, 
1976).  The proliferative response of Schwann  cells to axons 
can  also  be  observed  in  serum-free  medium;  under  these 
culture conditions  Schwann  cells relate to axons but do not 
ensheath or myelinate the nerve fibers (Moya et al.,  1980). It 
has previously been shown  that cell-cell contact  is required 
for the mitogenic response of Schwann cells to neurons (Salzer 
et al.,  1980a).  Furthermore,  neurite membrane fractions are 
mitogenic  for Schwann  cells,  whereas  conditioned  medium 
from dorsal root ganglion cultures is not (Salzer et al., 1980 b). 
One  or  more  of  the  components  on  the  neuron  surface 
required for this response are proteins, since they are sensitive 
to treatment with trypsin (Salzer et al.,  1980a). It has recently 
been reported that axolemmal preparations from brain (Cassel 
et al.,  1982; DeVries et al.,  1983; Sobue et al.,  1983), as well 
as PC12 cells (a rat pheochromocytoma) (Ratner et al.,  1984) 
provide mitogenic stimuli for Schwann cells. In none of these 
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cases has the mitogenic moiety been identified. 
Specific inhibitors of macromolecular synthesis can provide 
additional  insights into the chemical nature  of the Schwann 
cell mitogen present on the surface of the dorsal root ganglion 
neurites,  and  thereby  aid  in  the  purification  of these  mole- 
cules. 
In this paper, we describe the use of 4-methylumbelliferyl- 
fl-o-xyloside, a competitive substrate for the galactosyl trans- 
ferase required for the synthesis of the gal-gal-xyl oligosaccha- 
ride which links the carbohydrate chains of proteoglycans to 
the  core  proteins  (Robinson  et  al.,  1975;  Galligani  et  al., 
1975). It has been demonstrated that the effect of xylosides is 
specific for the  /3-o-xyloside anomeric  linkage  and  glycone 
(Robinson et al.,  1975; Galligani et al.,  1975).  In all systems 
studied,  treatment  of cells  in  culture  with  permeable  /3-D- 
xyloside  results  in  accumulation  of free glycosaminoglycan 
chains in the media (Galligani et al.,  1975;  Lohmander and 
Hascall,  1979; Thompson and Spooner,  1983; Kanwar et al., 
1984), as well as inhibition  of glycosaminoglycan addition to 
proteoglycan core proteins.  Synthesis of all the xylose-linked 
proteoglycans is potentially  inhibited  by the addition  of ex- 
ogenous 13-o-xyloside, including  chondroitin  sulfate,  derma- 
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localized to cell surfaces.  For example, a chondroitin sulfate 
proteoglycan has been localized on fibroblast surfaces (Hed- 
man et al.,  1983), several cell surface-derived heparan sulfate 
proteoglycans have been isolated from various sources (Car- 
lstedt et al.,  1983, and references therein), and a dermatan 
sulfate proteoglycan has been isolated from rat ovarian gran- 
ulosa cells  (Yanagishita and HascaU,  1984).  Cell-associated 
proteoglycans of neuronal origin have also been identified; 
these appear to be predominantly of the heparan sulfate class 
(Lander et al.,  1982; Hampson et al.,  1984;  Maresh et al., 
1984; Morris,  1984) and heterogeneous with respect to mo- 
lecular size and glycosaminoglycan fine structure. One chon- 
droitin sulfate/dermatan sulfate proteoglycan has also been 
identified (Aquino et al., 1984; Morris, 1984). We now present 
evidence that a surface-attached heparan sulfate proteoglycan 
is a component of  the axonal mitogen for Schwann cells. Our 
evidence is based on use of  4-methylumbelliferyl-13-D-xyloside 
as an inhibitor of proteoglycan biosynthesis, and on specific 
digestion  of the  neuronal  cell  surface  proteoglycans with 
hydrolytic enzymes. 
MATERIALS  AND  METHODS 
Cell Culture (Neurons):  Embryonic day 15 rat fetuses were obtained 
from timed pregnancies from a local supplier. Spinal cords were removed from 
the embryos by the method described by Salzer et al. (1980b),  so that dorsal 
root ganglia remain attached to the cord. Ganglia were then removed from the 
cords  in  sterile  L  15  medium containing  10%  fetal calf serum.  Using  this 
method,  800 dorsal root ganglia can easily be obtained from 20 spinal cords in 
2 h. Ganglia are dissociated by incubation in 0.25 % trypsin (Cooper Biomedical, 
Inc., Malvern,  PA) in Ca++/Mg÷+-free Hank's buffered salt Solution (CMF) ~ 
for 30 min at 37"C. Several rinses in serum-containing  medium (Dulbecco's 
modified Eagle's medium [DME] with 10% fetal bovine serum (KC Biological, 
Lenexa~ KS), 6 mg/ml glucose, 2 mM glutamine,  10-20 units of nerve growth 
factor) were followed by trituration  of ganglia through a  narrow-bore  glass 
pipette,  which  generates  a  single cell suspension,  Cells were plated  at  five- 
ganglia equivalents in a single small drop onto the center of ntiric acid-washed 
glass cover  slips (22  mm) (Bellco Glass,  Inc.,  Vineland,  NJ),  coated  with 
ammoniated rat tail collagen. Alternatively, 40-gangha equivalents of  cells were 
plated in 3 ml of serum-containing  medium onto collagen-coated tissue culture 
plastic lids from 35-mm dishes. In either case, cultures were re-fed the following 
day  with  antimitotics  (DME  with  10%  human placental  serum,  6  mg/ml 
glucose, 2 mM glutamine,  10-20 units of nerve growth factor,  10  -5 M uridine, 
10  -5 M  fluorodeoxyuridine).  10  -5 M cytosine arabinoside  was added  to this 
medium for 24 h in the  case of the mass (40 gangha/35-mm dish) cultures. 
This treatment  was found to be essential in order to generate supporting cell- 
free cultures  of neurons in  these  dense  cultures.  In both types of cultures, 
antimitotic  treatment  was continued  for 10 d, then cells were pulsed for 2-3 d 
with serum-containing  medium, and returned to antimitotics  for an additional 
1-2 wk. In the absence of nonneuronal cells, we have observed degeneration 
of neurons when cultures are maintained  longer than 3-4 wk. 
Schwann Cell Culture:  All experiments described in this paper have 
been repeated on two populations  of Schwann cells: those derived from dorsal 
root ganglia, which are prepared exactly as described in Ratner  et al. (1984), 
and those derived from sciatic nerve, essentially as described by Brockes et al. 
(1979). Sciatic nerve-derived  cells were transferred  to cytosine arabinoside- 
containing  medium 00  -5  M)  for 48  h  prior to anti-thy  l.l  treatment  and 
complement lysis of contaminating  fibroblasts. We have found culture  super- 
natant from the cell line ATCC TIB  103 (Lake et al.,  1979) (American Type 
Culture  Collection,  Rockville, MD) to be an effective source of anti-thy  l.l. 
Suspensions  of Schwann  cells from  either  of these  two sources were either 
replated onto glass multiwell Lab-Tek slides (Miles Laboratories, Inc., Elkhart, 
IN) and allowed to recover for 2 d prior to the mitogenicity assay (see below) 
or added to dissociated neurons on glass coverslips. The difference between the 
two Schwann cell populations  was found to be solely quantitative;  that is, the 
sciatic nerve cells were consistently more responsive to neurons or neuronal 
membranes than dorsal  root ganglion-derived  Schwann  cells (e.g., contrast 
~  Abbreviations  used in  this paper.  CMF,  Ca++/Mg++-free Hank's 
buffered salt solution; DME, Dulbecco's modified Eagle's medium. 
Table I!, in which dorsal root ganglion--derived Schwann cells were used, with 
Fig. 4, in which sciatic nerve-derived cells were used to do a similar experiment). 
Co-culture Experiments:  2-3  x  lO  4 Schwann cells were added  to 
dorsal root ganglion neurons on collagen-coated coverslips, which by the time 
of addition contained extensive neuritic outgrowth between neuronal somas in 
the original drop and also extending radially from the original drop. After 24 h 
of co-culture in normal serum-containing medium, Schwann cells settled onto 
neurons and began to proliferate. Cultures  were then re-fed with serum-free 
medium (Bottenstein and Sato, 1979) for 3-4 d in order to expand populations 
of Sehwann cells. At the end of this time, many neurites were sparsely covered 
with Schwann cells, and maximal proliferation of Schwann cells was occurring. 
Mitogenicity Assays:  Schwann cells plated onto Lab-Tek glass slides 
at a concentration  of 1.5-2 x  104 cells/well (8-well slides, 0.83 cm  2 wells) were 
allowed to  recover  from  trypsinization  for 48  h,  then  soluble  mitogens  or 
membrane fractions  were added  for  16  h  in  DME,  10%  fetal calf serum, 
penicillin (50 U/ml), streptomycin  (50 tJg/ml), and fungizone (2.5 #g/ml),  all 
obtained  from Gibco Laboratories, Grand Island, NY). Fungizone prevented 
contamination  of wells by yeast which was a serious problem  since we have 
stopped UV-irradiating membranes (Salzer et al., 1980b) prior to addition  to 
assays, because we observed  that  UV treatment  caused  variable  and  often 
profound inactivation of the mitogenic activity of the membranes. Membranes 
were readded to wells for an additional 24 h in fresh medium containing 2 #Ci/ 
ml  [3H]thymidine  (6.7 Ci/mol,  New  England  Nuclear,  Boston,  MA)  and 
dialyzed fetal calf serum. 
Fixation and Autoradiography:  24  h later,  media  was aspirated 
from the wells and replaced with 4% glutaraldehyde (EM grade, Sigma Chemical 
Co., St.  Louis, MO) in  Tris-boffered saline. After  1 h at room temperature, 
wells were washed four times over a 45-min  period with water; the attached 
gasket was removed from the slides; and the slides were air dried, dipped with 
Kodak NTB-2 emulsion and exposed for 72 h. Slides were then developed and 
stained with toluidine blue as detailed in Salzer and Bunge (1980). 400-1,000 
cells were counted per well to determine  percent labeled nuclei, and duplicate 
samples were counted  in each experiment.  Coverslips containing  co-cultures 
were fixed and washed as described for slides, then lifted out of Linbro wells 
using forceps, and dried in a laminar flow hood, mounted culture-side up onto 
a standard  microscope slide in DPX mountant (Gallard-Schlesinger Chemical 
Mfg. Corp., Carle Place, NY) and allowed to dry overnight before dipping in 
emulsion. At least 600 cells were counted in duplicate cultures in these experi- 
ments. 
Inhibitor Studies:  a-Methyl  xyloside, 4-methylumbelliferyl-/3-D-xylo- 
side, and 4-methylumbeUiferyl-a-L-arabinoside (obtained from Sigma Chemical 
Co.) were dissolved at  100  mM in dimethyl  sulfoxide. Stock solutions  were 
stored  in  the  refrigerator,  from which  they  were  added  to  medium,  filter 
sterilized, and used as described in the text. 
Enzyme Digestions:  Chondroitinase  ABC and heparitinase were ob- 
tained from Miles Laboratories Inc. and heparinase was obtained  from either 
Miles  Laboratories  Inc.  or  Sigma  Chemical  Co.  Enzymes  were  stored  as 
suggested by the supplier. Chondroitinase digestions were carried out in CMF 
since this enzyme can be inhibited by Ca  ++ (Banerjee et al., 1977). In control 
experiments, treatment  with the salt solution alone had no effect on mitogen- 
icity of cultures (data  not shown). Heparatinase  and heparitinase  digestions 
were carried out in serum-free medium, since these enzymes are activated and/ 
or stabilized by Ca  "+. Digestions of cell surface protein using 238 U/mg TPCK 
trypsin (Cooper Biomedical, Inc.) used 1 mg/ml of enzyme in CMF, and were 
stopped after 30 min by removal of enzyme solution  followed by addition  of 
CMF containing  10 mg/ml soybean trypsin inhibitor  (Sigma Chemical Co.). 
This relatively high concentration  of trypsin is necessary to completely destroy 
mitogenic activity (Salzer et al., 1980a). 
[3sS]-H2-S04 Labeling of Cultures:  4-wk-old dissociated dorsal 
root ganglion neuron cultures on plastic lids, which were observed using phase- 
contrast  optics to be free of nonneuronal cells (<1  nonneuronal cells/5  10x 
fields) were labeled in serum-free medium (Bottenstein and Sato,  1979) made 
with  SO4-free DME  (in  which  MgSO4 is exchanged  for  MgCI2), instead  of 
normal DME, and containing 800 vCi/ml [35S]-H2SO4, added from a 15-mCi/ 
ml  stock  obtained  from New England  Nuclear.  The final  concentration  of 
sulfate  in  this  medium  is  3.7  #M.  Cultures  were  labeled for -20  h,  and 
incorporated  in 1-2 x  104 trichloroacetic acid-precipitable  dpm/culture. 
Precipitations with  Trichloroacetic Acid:  5-~1  aliquots  of ex- 
tracted cultures or membrane preparations were spotted onto Whatman No. 3 
paper squares (Whatman Laboratory  Products  inc.,  Clifton,  N  J) and placed 
into a container of 10% trichloroacetic acid, heated at 100*C for 10 min, cooled 
on ice, rinsed  with  10%  trichloroacetic  acid, acetone,  and counted  in  3a70 
scintillation cocktail (Research Products International  Corp., Mr. Prospect, IL). 
Cell Extracts:  After sulfate labeling, dorsal root ganglion cultures were 
washed 3 times with I-2 ml ice cold CMF, scraped up from the tissue culture 
RATNER ET AL.  Schwann  CelIProliferation  745 plastic with a  forceps (along with the  collagen substrate)  and placed  into  a 
microfuge tube with 200 #1 of extraction  buffer (CMF,  1 mM CaCI2, 1 mM 
MgCI2,  1 rng/ml soybean trypsin inhibitor,  1 mM phenylmethylsulfonyl fluO- 
ride, 0.5% Triton X-100, 0.1% SDS). Cells were extracted on ice for 5 min, 
then centrifuged in the microfuge to remove intact nuclei and collagen. Super- 
natants were collected, radioactivity  was determined  by trichloroacetic  acid 
precipitation,  and supernatants  were loaded onto polyacrylamide gels. 
Membrane Preparation:  Mass dorsal root ganglion cultures on col- 
lagen-coated plastic were rinsed 2-3 times with CMF, scraped from the plastic 
along with the collagen substrate, and placed into a 1-ml dounce homogenizer 
(Wheaten  Scientific, Millville, N  J) containing 0.7 ml of ice cold buffer (0.25 M 
sucrose, 0.1  mM MgClz, l0 mM Tris-HC1, pH 7.4, 17 mU/ml aprotinin).  The 
ceils were disrupted with 50 strokes of the homogenizer, then centrifuged in a 
disposable borosilicate tube (10 x  75-mm) for l0 rain at 1,500 rpm in a table- 
top clinical centrifuge  at room temperature.  The supernatant was carefully 
removed  into  a 0.65-ml  nitrocellulose tube and placed into  adaptors  for an 
SW50.1 rotor and centrifuged at 45,000 rpm for 30 min at 4"C. The resulting 
pellet was resuspended in 100-300 ~tl of  the same buffer; the yield of  membranes 
from 3-4-wk-old cultures varied with the percent surviving neurons,  but was 
usually in the range of 100-300  #g membrane protein/culture  as assayed by 
the modification of the Lowry procedure for membrane proteins (Markwell et 
al., 1978). 
PAGE and  Fluorography:  Gels  were prepared  as described  (Lae- 
mmli,  1970). 6%  resolving gels contained  2.5% stacking gels, and  15%  and 
10% gels had 5% stacking gels. Four times solubilization mix contained  40% 
glycerol, 20%  ~-mercaptoethanol,  20 mM Tris base, pH 8.0, 12% SDS. After 
electrophoresis at 50 mA/slab, gels were fixed in 10% acetic acid, 25% isopro- 
panel  and prepared  for fluorography  using EN3HANCE (New England  Nu- 
clear). Gels were dried and exposed to Kodak XAR film at -70"C. 
Soluble Schwann Cell Mitogens:  Cholera  toxin (obtained from 
Sigma Chemical Co.) was solubilized and used within 2 me of solubilization. 
Glial growth factor was prepared from lyophilized bovine pituitary glands (Pel- 
Freeze Biologicals, Rogers, AR) as described by Brockes et al. (1980). The crude 
CM-cellulose fraction was used in these experiments. 
RESULTS 
In initial experiments, Schwann cells and dissociated dorsal 
root ganglion neurons were co-cultured in serum-free media 
for several days (see Materials and Methods). These cultures, 
with  vigorously proliferating populations of Schwann  cells, 
were incubated for 72 h with  1 mM 4-methylumbelliferyl-B- 
D-xyloside.  During  the  last  24  h,  2  uCi/ml  [aH]thymidine 
were added to control and drug-treated cultures. Fig.  1 shows 
an example of such a culture, in which the percent of Schwann 
cells whose nuclei were labeled with [3H]thymidine (as assayed 
by autoradiography) decreased by 80% in the presence of the 
drug (Fig.  1  B) as compared to the control (Fig.  1A), in which 
the percent labeled nuclei was 39.5%. 
The unexpected effect of an inhibitor of proteoglycan bio- 
synthesis on mitogenicity prompted us to undertake several 
control experiments to ascertain that the effect of the inhibitor 
was specific.  The effects of a-methyl-D-xyloside and 4-meth- 
ylumbelliferyl-a-L-arabinoside on Schwann cell proliferation 
was compared with that of  4-methylumbelliferyl-/~-D-xyloside; 
a-methyl-D-xyloside has previously been shown to be ineffec- 
tive as a substrate for galactosyl transferase (Robinson et al., 
1975 ) and 4-methylumbelliferyl-/~-D-arabinoside  was included 
to control for the enhanced lipophilicity of the umbelliferyl 
moiety. Neither glycoside at 1 mM was able to substitute for 
4-methylumbelliferyl-#-D-xyloside  in inhibiting Schwann cell 
proliferation (Table I), suggesting that 4-methylumbelliferyl- 
/~-D-xyloside is acting specifically in this system. 
If  B-xyloside is blocking proteoglycan assembly as described 
previously for other  cell  types,  ~-o-xyloside-linked glycos- 
aminoglycans should accumulate in the culture media in the 
presence of the drug (Galligani et al.,  1975; Lohmander and 
Hascall et al.,  1979; Thompson and Spooner,  1983). There- 
fore cultures of dorsal root ganglion neurons, free of nonneu- 
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renal cells, were labeled with [358]-504, and the macromole- 
cules present in the culture medium of control and xyloside- 
treated cultures were analyzed by PAGE followed by fluorog- 
raphy.  As  shown  in  Fig.  2,  several  [asS]-SO4-1abeled high 
molecular  weight  bands  can  be  observed  in  media  from 
control cultures. These presumably represent neuronally de- 
rived secreted proteoglycans, since they are completely absent 
in  4-methylumbelliferyl-/~-o-xyloside-treated  cultures.  In 
contrast, in inhibitor-treated cultures, considerable radioactiv- 
ity now migrates near the dye front.  Fig.  2B demonstrates 
that this material is sensitive to degradation by chondroitinase 
ABC.  Some  sensitivity to  heparitinase  is  also  observed al- 
though no glycosaminoglycan chains remain after chondroi- 
tinase ABC digestion. Since commercial heparitinase is con- 
taminated by chondroitinase (Dr.  A.  Caplan, Case Western 
Reserve, Cleveland, Ohio, personal communication), we as- 
cribe this degradation to contamination of the enzyme which 
is  apparent  at  the  high  levels  of enzyme  used  to  ensure 
complete degradation of glycosaminoglycan chains. 
We determined the dose of 4-methylumbelliferyl-~-D-xy- 
Ioside necessary to inhibit Schwann cell proliferation (Fig. 3). 
Half-maximal inhibition  of Schwann  cell  proliferation  oc- 
curred at 0.7 mM 4-methylumbelliferyl-#-o-xyloside;  80-85 % 
inhibition is routinely obtained using  l-raM concentrations 
of inhibitor. 
To test whether the inhibitor is affecting the neuron, the 
Schwann cell,  or both cell types, cultures of either neurons 
alone  or  Schwann  cells alone were treated  with  1 mM  4- 
methylumbelliferyl-t3-D-xyloside or  I  mM a-methyl-D-xylo- 
side,  after which the two cell types were recombined in the 
presence or absence of inhibitor (Table II). Preincubation of 
neurons with 4-methylumbelliferyl-fl-D-xyloside inhibits the 
mitogenic response by ~80% when the inhibitor is not present 
during the co-culture of the  two cell types, and  essentially 
totally when present throughout the experiment, suggesting 
that neurons are affected by treatment with the drug and that 
significant recovery of the mitogen(s) on the neuronal surface 
can take place during the 24-h co-culture. In contrast, prein- 
cubation of Schwann cells for 4 d with 4-methylumbelliferyl- 
~-D-xyloside  did not prevent their mitogenic response when 
added back to neurons in the absence of inhibitor, suggesting 
that the inhibitor either has no effect on Schwann cells or that 
the recovery from the inhibitor can be extremely rapid. 
Two types of experiments indicate that the Schwann cell 
response is not affected by treatment with 4-methylumbelli- 
feryl-~-D-xyloside.  First,  protein  synthesis  in  drug-treated 
Schwann cells is close to normal: 1 mM 4-methylumbelliferyl- 
fl-D-xyloside-treated Schwann cells incorporated [3SS]methi- 
onine into trichloroacetic acid-precipitable material at 88% 
of control  levels (quadruplicate  cultures  assayed,  data  not 
shown). Second, as shown in Table III, replated Schwann cells 
are competent to respond to soluble Schwann cell  mitogens 
(cholera toxin and glial growth factor) (Raft et al.,  1978) in 
the presence of  the drug, indicating that 4-methylumbelliferyl- 
fl-D-xyloside  treatment  does  not  prevent the  Schwann  cell 
from traversing the cell cycle. However, it is possible that the 
receptor for the neuronal mitogen which we presume exists 
on the Schwann cell surface might be specifically affected by 
the drug, especially since Schwann cells in culture have been 
shown to synthesize two proteoglycans, one of which appears 
to be associated with the cell  surface and contains heparan 
sulfate (as well as chondroitin sulfate) chains (Mehta, H., C. 
Orphe,  M.  S.  Todd,  C.  J.  Cornbrooks,  and  D.  J.  Carey, FIGURE  1  Treatment  with  1  /~M  4-methylumbelliferyl-~-D-xyloside  decreases  the  fraction  of  proliferating  Schwann  cells  in 
neuron-Schwann cell cultures.  (A)  Bright field photomicrograph of toluidine blue-stained autoradiograph of a control neuron- 
Schwann cell culture. Neurite bundles are shown, with Schwann cell nuclei, both labeled and unlabeled, associated with fascicles. 
(B) Parallel culture treated for 72 h with 1 mM 4-methylumbefliferyl-~-D-xyloside before fixation and autoradiography. Schwann 
cells are associated with neurites as in the control, yet few labeled nuclei are observed. Bar,  10 ~,m. 
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Experiment 
Addition  1  2  3 
Control  39.5  19.6  52.0 
4-Methylu  m belliferyl-/~-D-xyloside  2.2  0.3  12.5 
a-MethyI-D-xyloside  ND  21.2  ND 
4-Methylumbelliferyl-e-L-arabinoside  ND  ND  48.0 
Schwann cells were co-cultured with dorsal  root ganglion  neurons  as de- 
scribed  in Materials and Methods. Where indicated,  1 mM inhibitors  were 
added for 72 h, and  [3H]thymidine was present during the last 24 h. After 
fixation and autoradiography,  the percentage of Schwann cell nuclei which 
has incorporated [3H]thymidine was determined. ND, not done. 
FIGURE  2  Analysis of secreted dorsal root ganglion neuronal pro- 
teoglycans.  Neurons  are  metabolically  labeled  with  [3ss]-so4  in 
serum-free, SO4-free medium, and 100-/.d aliquots of medium were 
analyzed by electrophoresis on a 6% polyacrylamide gel, followed 
by fluorography. (A) Lane 1, control medium. Lane 2, medium from 
a  culture  to  which  1  mM  4-methylumbelliferyl-/~-D-xyloside was 
added along with the isotope. Molecular masses  in the left margin 
indicate the positions of migration of myosin (205 kD), ~-galactosid- 
ase (116 kD), phosphorylase b  (98 kD), and bovine serum albumin 
(66  kD).  (B)  Aliquots  (10  #1)  of  conditioned  medium  from  S-D- 
xyloside-treated  neurons  were  digested  with  glycosaminoglycan 
hydrolases (0.25 units) for 2.5 h, separated on 15% acrylamide gels, 
and  subjected  to fluorography. These concentrations of enzymes 
are 100 times those used to digest cell surfaces to ensure complete 
degradation.  Lane  1,  heparitinase  digested.  Lane  2,  heparinase 
digested  (same as control).  Lane 3,  chondroitinase ABC  digested. 
Molecular  masses  in  the  right  margin  indicate  the  positions  of 
migration of  bovine  serum  albumin  (66  kD),  ovalbumin  (45  kD), 
pepsin (36  kD),  carbonic anhydrase (29 kD), trypsinogen (24 kD), 
and  trypsin  inhibitor  (20  kD).  Molecular  masses  refer to  proteins 
and cannot be taken to directly correspond to the molecular mass 
of proteoglycans, which migrate abnormally in SDS gels due to their 
intrinsic negative charge. 
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FIGURE  3  Dose-response relationship of inhibition of Schwann cell 
proliferation to increasing concentrations of 4-methylumbelliferyl- 
/~-D-xyloside. Schwann cell-neuron cultures in serum-free medium 
were treated with  4-methylumbelliferyl-/3-D-xyloside. After  a  total 
of 72  h  in the presence of the drug, with  2  #Ci/ml  [3H]thymidine 
present during the last 24 h, duplicate cultures were processed for 
autoradiography and labeled Schwann cell nuclei counted. Percent 
labeled  Schwann  cell  nuclei  in  duplicate  cultures  varied  by  less 
than 5%. 
TABLE II.  ~-o-Xylosi'des Block the Expression of the Dorsal Root 
Ganglion  Surface Mitogen 
Pretreatment 4 d 
Co-culture  %  [3H]thymidine-la- 
Neurons  Schwann cells  1 d  beled Schwann cells 
--  --  --  4.8  (4.0,  5.5) 
a-D-xyl  --  --  5.1  (5.0, 5.1) 
13-D-xyl  --  --  1.0 (1.0, 0.9) 
fl-o-xyl  --  fl-D-xyl  0.2 
--  fl-D-xyl  --  6.0 (6.3, 5.6) 
The cells indicated, either neurons or dorsal root ganglion-derived Schwann 
cells, were incubated with additions indicated for 4 d in serum-free medium. 
Schwann  cells  were  isolated  as  described  and  held  overnight following 
enzymatic  dissociation in the continued presence of inhibitor prior to addition 
to  neurons.  The  low labeling indices  in  this  experiment are  due  to  this 
protocol.  Schwann  cells  and  neurons  were  combined with  additions as 
indicated  and  incubated  for 24 additional h with  1 ~tCi/ml [3H]thymidine, 
followed  by  fixation  and  autoradiography to  determine  the  fraction  of 
Schwann cells with labeled nuclei.  Lnhibitors were all added at 1 mM. ~-D- 
xyI, 4-methylumbelliferyl-~-D-xyloside;  a-•-xyI,  a-methyl-n-xyloside. Num- 
bers in parentheses are results from single cultures to show range of values. 
TABLE III.  Effect  of 4-Methylumbelliferyl-13-a-Xyloside  on the 
Response of Schwann Cells to Soluble Mitogens 
%  Labeled Cells 
Addition  Exp. 1  Exp. 2 
None  68.7  65.4 
a-o-xyl  84.7  76.4 
~-o-xyl  73.8  75.8 
Schwann cells replated onto glass slides as described were incubated with 1 
mM xyloside for 24 h, followed by the addition of 50/zgJml partially purified 
glial growth factor and 20 ng/ml cholera toxin. After 15 h, [3H]thymidine was 
added for a further 24 h, cells were fixed and processed for autoradiography, 
and the fraction of labeled cells determined. Abbreviations  as in Table I. The 
percent  of labeled  nuclei  in the absence of added mitogen was 0.2% in 
experiment 1 and 0.7% in experiment 2. 
manuscript  submitted  for publication).  Therefore,  we  com- 
pared the time course of the effect of 4-methylumbelliferyl-/~- 
D-xyloside treatment  on neuron plus  Schwann  cell  cultures 
with the  time  course  of its effect  on  neurons  pretreated  for 
various lengths of time followed by co-culture with Schwann 
cells for 24 h. As shown in Fig.  4, 4-methylumbeUiferyl-3-o- xyloside treatment caused inhibition of Schwann cell prolif- 
eration with essentially the same kinetics and extent in both 
protocols. We therefore conclude that the major, if not the 
only, effect of 4-methylumbelliferyl-/~-D-xyloside  is on a pro- 
teoglycan on the neuronal surface. This experiment also al- 
lows  us  to  conclude  that  the  t,/~ of the  neuronal,  xyloside- 
sensitive component related to the mitogenic activity is ~ 12 
h. 
If proteoglycans  on  the  surface  of dorsal  root  ganglion 
neurons are required in order to elicit a  mitogenic response 
in Schwann cells, then removal of these molecules from the 
neuronal  surface  by treatment  with  appropriate hydrolytic 
enzymes  should  inhibit  the  mitogenic  response.  Heparan 
sulfate and chondroitin sulfate appear to be the major proteo- 
glycan species in  dorsal  root ganglion  cells,  at least in  the 
chick (Chernoff,  1984).  We therefore treated co-cultures of 
Schwann cells and neurons with enzymes which degrade these 
molecules. As shown in Fig. 5 A, incubation with chondroitin- 
ase ABC had no inhibitory effect on the mitogenic response, 
although  in  control  experiments the  enzyme was active in 
removing [3sS]-labeled  proteoglycans from PC I2  pheochro- 
mocytoma cells (data not shown).  In contrast, treatment of 
the cultures with the combination of heparinase and hepari- 
tinase inhibited the mitogenic response (over 50%), without 
apparent alteration of cell morphology. In later experiments, 
digestion of the neuronal cell surface with heparitinase alone 
prior to the addition  of Schwann cells was found to mimic 
the effect of the combination of the two enzymes on neuron 
and  Schwann  cells  together  (Fig.  5B).  We  conclude  from 
these experiments that a neuronal cell surface heparan sulfate 
proteoglycan  is  required  to  elicit  a  mitogenic  response  in 
Schwann cells. 
To ensure that our heparitinase preparation is not contam- 
inated by protease, we digested a  solubilized preparation of 
dorsal root ganglion membrane proteins with a 23-fold excess 
of enzyme (11.1  U/ml). Fig. 6 shows the effect of digestion of 
1 ug of extracted protein by enzyme for 1 h at 37°C in tissue 
culture  media.  Although  the  enzyme  is  clearly  active,  as 
evidenced by removal of [355]-504  from SO4-1abeled material 
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FIGURE  4  Kinetics  of  1  mM  4-methylumbelliferyl-i~-o-xyloside 
treatment. Cultures were treated with the drug for the number of 
hours  denoted on  the abscissa. The  open circles  show percent 
labeled Schwann cells  for cultures in which sciatic  nerve-derived 
Schwann cells, freshly scraped off plastic tissue culture dishes, were 
added to  neurons for the  final  24  h  of  the  inhibitor treatment. 
Closed circles are cultures in which Schwann  cells  were present 
throughout inhibitor treatment. For all data points, 2/~Ci/ml [3H]- 
thymidine were added during the final 24  h  of the experiment, 
after which  cultures were  fixed,  processed for autoradiography, 
and stained, and labeled nuclei were counted. 
A  NEURONS 
ImM  ~-D-xylo$ide  - 
24h 
m  30'  "'" 
ri/ 
~  rip 
SCHWA  NN  CELLS 
Chondmifinose  Heporinose 125 mUlrnl 
250mU/ml  Heporitinose  125mU/ml 
I h- 37"C  I h, 37"C 
+  +  + 
¢11 
vl.n  Ell 
vl.,n  El., 
Y/A  . -. 
Schwann cells  added  + 
3mM  /3'-O-xyl,  - 
30l-  .~ 
61 _ 
._1 
_.1 
/p 
// 
ifJ 
NEURONS 
I  '  Heparitinase 
500 mU/ml 
I  h  57°C 
I-  ÷ 
+  + 
// 
,/, 
FIGURE  5  Reduction of mitogenic stimulation of Schwann cells by 
digestion of the neuronal surface with heparitinase. (A) Neuron- 
Schwann cell co-cultures were digested with either chondroitinase 
ABC or heparitinase  plus heparinase under the indicated conditions. 
The cultures were then incubated for 12 h in the presence of 1 mM 
4-methylumbelliferyl-#-D-xyloside  to prevent resynthesis of proteo- 
glycans and to allow any cells  already in the S phase of the cell 
cycle to complete DNA synthesis, and then for an additional 12 h 
in the presence of inhibitor plus 2 #Ci/ml [3H]thymidine prior to 
fixation and processing for autoradiography. Labeled Schwann cell 
nuclei were counted as usual. Duplicate cultures were within 10% 
of the mean. (/3) Cultures of neurons without Schwann cells were 
digested with heparinase or heparitinase under the indicated con- 
ditions. After enzyme digestions,  untreated sciatic  nerve-derived 
Schwann  cells  were scraped off tissue  culture plastic dishes  and 
added to neurons in fresh  medium. Addition of 4-methylumbelli- 
feryl-/:~-o-xyloside and [3H]thymidine were as described above, and 
were followed by autoradiography. Duplicate cultures were within 
15% of the mean. 
from parallel cultures,  no change in mobility or any of the 
many methionine-labeled proteins present in this preparation 
were detected after electrophoresis on  10%  polyacrylamide 
gels followed by autoradiography. In addition, the defned N2 
medium  used  in  the  heparitinase  digestion  of dorsal  root 
ganglia cultures contains  a  total  of 15.1 ~g/ml of protein, 
mostly bovine serum albumin, which would act as an inhibi- 
tor of nonspecific protease. Though we cannot rule out an 
effect of a  very specific protease on the mitogen itself,  this 
experiment indicates that the heparitinase preparation is not 
contaminated  by  a  general  protease;  this  is  an  important 
control since it has been established that the neuronal mitogen 
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ity.  A  proteoglycan-enriched fraction  was  prepared  by  extracting 
membranes from dorsal root ganglia neurites with 35 mM octylglu- 
coside, 0.5 M  NaCl, 0.15 mM EGTA in homogenization buffer. This 
extract was passed through a Biogel HTP column and the effluent, 
after dialysis, was digested for 1 h at 37°C with 300 mU of hepari- 
tinase  in  27  #1,  followed  by  PAGE  in  10%  gels.  Lanes  1 and  2, 
[~ss]-so4-1abeled cells. Lanes 3 and 4, [35S]methionine-labeled cells. 
Lanes  2  and  4  are  heparitinase  treated  and  lanes  I  and  3  are 
controls. Note that heparitinase degrades the proteoglycan (lane 2) 
while leaving protein intact (lane 4).  For details see text. 
is protease sensitive (Salzer et al.,  1980a, b; Cassel et al.,  1982; 
Ratner et al.,  1984), although high concentrations of protease 
are required to degrade the mitogen(s). 
Previous work from this laboratory (Salzer et al.,  1980b; 
Cassel et al., 1982; Ratner et al.,  1984) as well as from another 
(Hanson  and  Partlow,  1980)  has  demonstrated that  mem- 
branes prepared from dorsal root ganglion neurons are mito- 
genic  for  Schwann  cells.  The  notion  that  a  neuronal  cell 
surface heparan sulfate proteoglycan is required for the  mi- 
togenic  response would be strengthened  if membranes pre- 
pared  from  heparitinase-treated  neurons  or  from  neurons 
grown  in  the  presence of 4-methylumbelliferyl-/~-D-xyloside 
elicited  a  diminished  response  when  added  to  replated 
Schwann cells. The data in Fig. 7 A show dose-response curves 
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for membranes prepared from cultures treated with hepariti- 
nase immediately before membrane preparation. We observe 
a 30-60% reduction in mitogenicity of membranes prepared 
from  heparitinase-treated  neurons;  the  mitogenicity of the 
membrane fractions derived from these cultures is reduced to 
levels  similar  to  those  obtained  by trypsin  treatment.  We 
presume  that  at  least  a  portion  of the  residual  activity  is 
derived from a pool of intracellular membranes, inaccessible 
to the enzymes. The variation in the reduction of mitogenicity 
of treated membranes appears to depend  on the density of 
the neurons and neuritic outgrowth in the starting cultures, 
although this has not been studied systematically. 
Five separate experiments have been carried out to compare 
the mitogenicity of control membranes to that of membranes 
from cells grown in the presence of 1 mM 4-methylumbelli- 
feryl-~-D-xyloside.  Dose-response curves for all  five experi- 
ments show a similar trend: membranes from treated cultures 
are not as mitogenic as control membranes, yet they retain a 
significant amount of activity based on  amount of protein 
added to Schwann cells. A typical experiment is shown in Fig. 
7 B; at maximal stimulation, 66%  of the activity remains in 
membranes from neurons grown for 5 d in  l  mM 4-methy- 
lumbelliferyl-~-D-xyloside;  37.4%  remains  in  membranes 
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FIGURE  7  Membranes  prepared from  heparitinase-digested neu- 
rons or from  neurons grown  in  4-methylumbelliferyl-~-o-xyloside 
show diminished mitogenicity for Schwann cells. (A) Mass cultures 
of dorsal  root ganglion neurons  were used  as a  source  of  mem- 
branes. These cultures were digested with either trypsin or hepari- 
tinase as described, membranes prepared, and added to Schwann 
ceils replated onto glass  slides. A  second  addition of  membranes 
was made after 16 h, in the presence of [~H]thymidine. After 24 h, 
cultures  were fixed,  processed  for  autoradiography, and  labeled 
Schwann ceils counted. (B) Mass  cultures of neurons were grown 
for 5 d in the indicated concentration of 4-methylumbelliferyl-/~-D- 
xyloside. Membranes were then prepared and added to Schwann 
cells as described above. from neurons grown in 2 mM inhibitor. At these concentra- 
tions, remaining mitogenicity of intact neurons for Schwann 
cells would be at most 25% at  1 mM xyloside and  10% at 2 
mM  xyloside  after  3  d.  A  possible  explanation  for  these 
experimental  observations  is  that  the  core  protein  of the 
proteoglycan  (or a  linked  protein)  is  not  reaching  the  cell 
surface.  To test this hypothesis,  membranes were prepared 
from  neurites  alone  (essentially cell  surface membrane) or 
from cultures containing neurites as well as cell bodies (which 
contain  all  the  neuronal  Golgi apparatus and  endoplasmic 
reticulum).  Table  IV  shows  that  while  neurites  of control 
cultures  are  even  more mitogenic than  total  cultures  on  a 
protein  basis,  neurites  from  4-methylumbelliferyl-#-D-xylo- 
side-treated cultures are only 18.6%  as mitogenic as control 
membranes. This value agrees well with the percent inhibition 
obtained  in  xyloside-treated  neuron-Schwann  cell  co-cul- 
tures. 
Support for the hypothesis that the protein moiety of the 
proteoglycan (or another protein) is required for mitogenicity 
comes from the fact that exogenous heparan sulfate, obtained 
either from Miles Laboratories Inc.  or from Dr.  A.  Linker 
(Linker and Hovingh, 1973) and obtained from bovine lung, 
TABLE IV.  Effect  of 4-Methylurnbellifery##-D-Xyloside  or the 
Mitogenicity of Neuronal Cell Bodies and Neurites 
%  labeled 
cells  %  control 
Control  Cell bodies +  neurites  29.6 
Neurites only  36.2 
Xyloside treated  Cell bodies +  neurites  25.0  84.5 
Neurites only  5.5  18.6 
6 wk prior to use, dissociated and embryonic dorsal root ganglia were plated 
onto collagen substrata in drops containing  20 ganglia--equivalents of cells 
in  a 2-mm  drop. Antimitotic  treatment  was as described  in  Materials and 
Methods. 5 d  prior to use, half of the cultures  were treated  with  1 mm 4- 
methylumbelliferyl-#-o-xyloside.  Membranes  were prepared from cultures 
containing  neuronal somas and  neurites, or from cultures  from which  cell 
bodies were removed using a razor blade fragment. Membranes were added 
to replated  Schwann cells at  10 ~g/well  of Schwann cells in duplicate.  The 
percent labeled Schwann cells in the absence of membranes was 1%. 
is not able to stimulate replated Schwann cells to proliferate 
when  added  at  concentrations  up  to  100  #g/ml (data  not 
shown). (Heparin and chondroitin sulfate are similarly inac- 
tive.) Similarly, the addition of heparan sulfate, heparin,  or 
chondroitin sulfate to co-cultures of Schwann cells and neu- 
rons fails to show any inhibition of the mitogenicity induced 
in the Schwann cell population by the presence of  the neurons. 
These concentrations of polysaccharides are adequate to in- 
hibit cell-to-substratum adhesion in another system (Cole et 
al.,  1985). These negative results are open to multiple inter- 
pretations;  the  added  polysaccharides may have the  wrong 
structure, thus concentration may be wrong or they may not 
have adequate  access  to  the  surface  of the  Schwann  cell. 
Alternatively, these experiments may indicate that the protein 
moiety of the proteoglycan (or of another protein) is required 
to elicit a mitogenic response. 
We considered whether we could detect a xyloside-sensitive, 
heparitinase-sensitive moiety on  the  surface  of dorsal  root 
ganglion neurons which  is present in  mitogenic membrane 
fractions, since identification of such a molecule will facilitate 
its  isolation.  Therefore,  cultures  of neurons  were prepared 
(see  Materials  and  Methods),  solubilized,  and  subjected  to 
PAGE.  Fig.  8  shows  that  [3ss]-so4 incorporation  by these 
embryonic neurons leads to labeling of xyloside-insensitive 
components (sulfated proteins and glycoproteins) as well as 
xyloside-sensitive components (proteoglycans).  When  com- 
pared to protein standards, major neuronal xyloside-sensitive 
components show low mobility, i.e., apparent high molecular 
weight.  To determine whether any of the  xyloside-sensitive 
molecules showed homology with the proteoglycan involved 
in the mitogenic response, companion cultures were sulfate 
labeled, then digested with heparinase or heparitinase before 
preparation of cell  extracts. No sulfate-labeled material was 
removed by heparinase  (data  not  shown),  but  heparitinase 
significantly diminished labeling of material near the top of 
the  6%  resolving  gel.  This  material  is  surface  membrane 
associated, as demonstrated by the fact that it is sensitive to 
enzyme digestion of  the intact cell, and also since it is enriched 
FIGURE 8  [3sS]-SO4-1abeled  com- 
ponents  of  dorsal  root  ganglion 
neurons:  sensitivity  to  4-meth- 
ylu mbelliferyl-#-a-xyloside  and 
heparitinase  and  localization  in 
membranes.  Fluorogram  of  6% 
SDS  polyacrylamide gel.  Lane  1, 
cell  extract  of  control  neurons. 
Lane  2,  cell  extract  of  neurons 
digested  with  heparitinase.  Lane 
3,  cell  extract of  1  mM  4-meth- 
ylumbelliferyl - #- D - xyloside- 
treated  neurons.  Lane  4,  mere- 
brahe  fraction  prepared  from 
control  neurons.  Lane  5,  mem- 
brane fraction prepared from he- 
paritinase-digested neurons. Each 
lane contains the total protein iso- 
lated  from  one  mass  culture  of 
neurons. 
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dorsal root ganglion neurons contain  one or more heparan 
sulfate proteoglycans on their cell surfaces; however, we have 
not yet demonstrated that the material observed by fluorog- 
raphy of [35S]-SO4-1abeled material on polyacrylamide gels is 
related to the mitogen. 
DISCUSSION 
Two independent  approaches indicate  that  a  neuronal  cell 
surface proteoglycan, probably heparan sulfate, is required to 
elicit a mitogenic response in Schwann cells. This conclusion 
is based on the use of an inhibitor of proteoglycan synthesis 
as well as an enzymatic digestion of intact neurons. Though 
each of these approaches has potential pitfalls, the use of both 
reinforces the conclusion that a proteoglycan is required for 
this mitogenic effect. In parallel studies (Ratner, N., S. Porter, 
A. Elbein, R. P. Bunge, and L. Glaser, manuscript in prepa- 
ration),  we  have  shown  that  inhibitors  which  modify  the 
maturation (trimming) of asparagine-linked oligosaccharides 
on glycoproteins do not affect the mitogenic interaction be- 
tween neurons and Schwann cells. 
Cell surface heparan sulfate proteoglycans have been de- 
scribed on many cell types (Kawakami and Terayama, 1981; 
Carlstedt et al.,  1983; Rapraeger and Bernfield,  1983; Yana- 
gishita and Hascall, 1984) and, although the function of these 
cell  surface  molecules is  still  largely  unknown,  correlative 
evidence  suggests  that  proteoglycans can  be involved with 
growth control.  An  intact basal  lamina,  of which  a  major 
component is heparan  sulfate proteoglycan, is required  for 
proliferation of epithelial cells of which the corneal epithelium 
is an  example (Gospodarowitz et al.,  1982).  Many cells in 
tissue culture proliferate in the absence of exogenous growth 
factors when in contact with an extracellular matrix (Gospo- 
darowitz et al.,  1978).  Heparin itself,  a soluble glycosamino- 
glycan as opposed to a basal lamina component, acts syner- 
gistically  with  endothelial  growth  factor  (Thornton  et  al., 
1983; Maciag et al.,  1984) in stimulating survival and prolif- 
eration of human endothelial cells, while heparin inhibits the 
growth of smooth muscle cells in vitro and in vivo (Cochran 
et al.,  1984).  It is nevertheless surprising that a  cell surface 
heparan sulfate proteoglycan is important in growth control 
in the neuron-Schwann cell system. 
In several control experiments that have been carried out 
to substantiate that t3-D-xyloside is only acting as an inhibitor 
of proteoglycan biosynthesis in this system, we observed the 
following. (a) The effect of the inhibitor is specific for the 
xylose (t3-D-arabinoside  will  not substitute for ~-D-xyloside) 
as well as the anomeric linkage (only the ~3-xyloside inhibits 
Schwann cell proliferation). (b) Schwann cells are capable of 
responding to mitogens other than neurons in the presence of 
the  drug  (cholera  toxin  and  glial  growth  factor  stimulate 
Schwann cell proliferation in the absence oG3-D-xyloside). (c) 
Schwann cells treated with 4-methylumbeUiferyl-13-D-xyloside 
are capable of responding to intact neurons within 24 h after 
withdrawal  of the  drug.  (d)  Synthesis  of bulk  protein  by 
Schwann cells treated with 13-D-xyloside  as assayed by trichlo- 
roacetic acid-precipitable [35S]methionine-labeled protein is 
88%  of control  values.  (e)  Finally,  in  the  presence of the 
inhibitor,  synthesis  of the  normal  neuronal  proteoglycans, 
both cell associated and secreted, is halted, and small chon- 
droitinase ABC-sensitive material and free glycosaminogly- 
can chains are secreted into the culture medium. 
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We  have  also  used  enzymes  which  specifically degrade 
glycosaminoglycan chains to arrive at a  similar conclusion, 
that is, that a specific proteoglycan is required for the mito- 
genic response of Schwann cells to neurons to occur. Neither 
active preparations of chondroitinase  ABC  nor  heparinase 
reduced the mitogenicity of dorsal root ganglion neurons, but 
heparitinase pretreatment of neurons causes them to be much 
less effective than untreated controls in stimulating Schwann 
cell division, and heparitinase digestion of neurons prior to 
isolation  of membranes causes  these  membranes to  be  as 
inactive as membranes isolated from trypsin-treated neurons 
in  mitogenic  activity.  These  observations  substantiate  the 
hypothesis that a proteoglycan is involved in signal transduc- 
tion and, in addition, suggest that the active proteoglycan is 
a heparan sulfate proteoglycan. Some caution must be applied 
to interpretation of this result since it is based solely on the 
specificity of the  enzyme. The  neuronal  proteoglycan may 
contain  some linkages sensitive to  heparitinase,  which  are 
necessary to maintain the molecules' activity, and also contain 
other types of sugar chains. 
It is also necessary to ask whether it has been absolutely 
established that the proteoglycan is a cell  surface molecule, 
and  not  secreted  from  the  neuron  and  reattached  to  the 
collagen, either directly or as part of the extracellular matrix. 
Several pieces of information argue against these interpreta- 
tions. (a) Cultures of neurons, without supporting Schwann 
cells, do not contain a visible extracellular matrix (Bunge et 
al.,  1982).  (b) Even  when  many neurons  are present in  a 
culture, Schwann cells not in direct contact with neurons are 
not stimulated to divide (Wood and Bunge,  1975; Salzer et 
al.,  1980a). (c) Membrane preparations in which collagen is 
depleted by at least 75% (Salzer et al.,  1980b) are enriched in 
mitogenic activity. (d) Finally, PC 12-derived membrane frac- 
tions,  obtained  from PC12  cells  grown  in  suspension  and 
therefore free of collagen, contain a molecule mitogenic for 
Schwann  cells  (Ratner  et  al.,  1984);  PC12  cell-stimulated 
Schwann  cell  proliferation  is  reduced  by  50-60%  in  the 
presence of I mM 4-methylumbelliferyl-13-D-xyloside  (Ratner 
et al.,  1985), providing some evidence that similar mitogenic 
molecules are present in PC12 cells and dorsal root ganglion 
neurons. 
Our evidence strongly supports the hypothesis that a cell 
surface heparan sulfate proteoglycan is required for neurons 
to  stimulate  Schwann  cell  division;  however,  until  such  a 
molecule is isolated and tested directly for mitogenicity, we 
cannot distinguish  whether this proteoglycan is itself mito- 
genic for Schwann  cells  (and,  if so, whether the  mitogenic 
activity resides in the core protein or the glycosaminoglycan 
chain[s])  or  whether  the  proteoglycan is  a  co-factor for  a 
mitogenic activity residing in another neuronal surface mol- 
ecule. In fact, we do not know whether the core protein of 
the relevant heparan sulfate proteoglycan is inserted into the 
membrane after treatment with /3-D-xyloside; studies of the 
cellular location of proteoglycan core proteins of cell surface 
proteoglycans following treatment  with  /3-D-xylosides  have 
not  been  reported.  In  experiments  using  the  glycoprotein 
inhibitor tunicamycin, which generates core proteins without 
mature N-linked carbohydrate chains,  it appears that each 
oligosaccharide-free core protein behaves differently with re- 
spect to arrival at its proper destination (Olden et al.,  1985). 
If  the core protein of the mitogen is present on the cell surface, 
it is unable itself to elicit a mitogenic response in Schwann 
cells.  In addition,  a  population  of mitogenic molecules ap- pears to be retained in intracellular membranes before arrival 
at  the  cell  surface  (Table  IV).  These  molecules  may  lack 
sufficient  glycosaminoglycan side  chains  to  reach  the  cell 
surface, yet retain enough side chains to enable proper folding 
and therefore mitogenicity, either directly or as a co-factor for 
another cell surface molecule. 
In this  model, (a)  treatment of the  neuronal  membrane 
with heparitinase must abolish mitogenicity by removal of all 
the  glycosaminoglycan chains  on  surface  molecules,  since 
these are rendered nonmitogenic; and (b) increasing concen- 
trations  of/3-D-xyloside inhibit  mitogenicity of membrane 
fragments  by  progressive  decrease  in  the  leakiness  of the 
competitive inhibitor; at 1 mM B-t~xyloside most proteogly- 
cans may retain one or more glycosaminoglycan side chains, 
and therefore activity, whereas at 3 mM #-D-xyloside most 
proteoglycans may be naked core proteins, and therefore be 
nonmitogenic. 
The  cell  division  initiated  in  Schwann  cells  by neurons 
must  involve an  initial  adhesion  step;  Schwann  cells must 
contact  neurons  in  order  to  be  stimulated  to  divide  and 
recontact neurons following progress through the cell cycle. It 
is therefore of some interest to note that when the progress of 
Schwann cells through the cell cycle has been halted by the 
addition of 4-methylumbelliferyl-B-D-xyloside,  these cells still 
relate normally to axons (Fig.  1). Even at the growing tips of 
the axons, where the effects of  the inhibitor would be expected 
to be maximized due to insertion of newly synthesized protein 
(Pfenninger  and  Maylie-Pfenninger,  1981a,  b)  and  lipid 
(Pfenninger and Johnson, 1983), and presumably also proteo- 
glycans,  no  effect  is  observed  on  the  relationship  of the 
Schwann celt to the neurons. This finding should be compared 
to previous observations by Salzer et aI. (1980a) who showed 
that Schwann cells failed to adhere to or align with neurites 
previously fixed with glutaraldehyde or digested with trypsin. 
This data implies that a trypsin-sensitive (but not ~/-D-xylo- 
side-sensitive) molecule is the adhesion-mediating factor, and 
that long-term neuron-Schwann cell interaction in nondivid- 
ing Schwann ceils is not stabilized by 13-D-xyloside-sensitive 
components. However, we cannot rule out the possibility that 
(a) the core protein itself is responsible for cell-cell interac- 
tion, or that (b) since xyloside treatment is always leaky due 
to  competition  of native  core  proteins  with  the  drug,  the 
relatively few native proteoglycan molecules present in treated 
cells  suffice  to  maintain  adhesion  between  neurons  and 
Schwann  cells,  yet  are  insufficient  in  number  to  serve  as 
mitogenic signals.  Sobue and Pleasure (1985) have correlated 
binding of axolemmal fragments to Schwann cells with the 
mitogenic potential of  the membranes; we can now show that, 
although  adhesion is required for mitogenicity, the two are 
distinguishable events. 
The cell adhesion molecule Ng-CAM is a candidate mole- 
cule for maintainance of neuron-Schwann  cell interaction. 
This  molecule  (Grumet  et  al.,  1984)  may  be  present  on 
Schwann cells as well as neurons (Faissner et al., 1984; Gru- 
met  and  Edelman,  1984).  Antibodies  against  the  135-kD 
component of this molecule inhibit the interaction of neurons 
with central nervous system glia (Grumet et al.,  1984). 
Since a proteoglycan is so strongly implicated as a compo- 
nent of the mitogenic signal, it is of some interest that the 
extracellular matrix component, laminin, can bind to heparin 
(Shakashita  et al.,  1980;  Kleinman et al.,  1984)  and  is ex- 
pressed on Schwann cell surfaces (Cornbrooks et al.,  1983). 
In defined media, laminin is expressed as discrete patches on 
the Schwann cell surface (Cornbrooks et al.,  1983), although 
no basal lamina is formed under these conditions (Moya et 
al.,  1980). It is conceivable that the binding of heparin sulfate 
on the neuronal surface to laminin on the Schwann cell might 
result in  regulation  of the  mitogenic activity. Laminin has 
been shown to mediate Schwann cell-substratum interaction; 
anti-laminin antibodies cause detachment of Schwann ceils 
from the substratum (McGarvey et al.,  1984). However, since 
neither 4-methylumbelliferyl-l~-D-xyloside treatment nor he- 
paritinase digestion of neuronal surfaces decreases adhesion 
between Schwann cell and neuron, a laminin-heparan sulfate 
interaction is probably not the mediator ofintracellular adhe- 
sion in this system. 
The involvement of a  proteoglycan in  the  mitogenic re- 
sponse suggests a  possible mechanism  of regulation  of the 
mitogen, since proteoglycans can be degraded by extracellular 
heparitinases (Lark and  Culp,  1983).  Kalderon  (1984)  has 
suggested that plasminogen, activated by plasminogen acti- 
vator released from Schwann cells, might degrade a neuronal 
cell adhesion molecule, clipping from the neuronal surface a 
fragment mitogenic for Schwann cells. From previous exper- 
iments (Salzer et at.,  1980a), we know that if this mechanism 
is correct, the fragment must have a very short half-life or a 
very low concentration.  We  speculate that  heparan  sulfate 
chains  which  are  required  for mitogenicity can  be clipped 
from the neuronal surface by heparitinases and in this way 
inactivate the mitogen, providing a mechanism for regulating 
Schwann cell-neuron interaction. 
In  conclusion,  our  results  demonstrate  that  cell  surface 
heparan  sulfate  is  a  specific  component  required  for  the 
mitogenic response of Schwann cells to neurons, suggesting  a 
unique biological function for heparan sulfate proteoglycans 
in the nervous system. 
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